H, J., E, L., JS, R., JY, L., & J, B. (2023). Mortality After Acute Coronary Syndrome in Human Immunodeficiency Virus Infection with Optimal Adherence: A Nationwide Study. Infection & chemotherapy, 55(4), 471. https://doi.org/10.3947/ic.2023.0050
Chicago Style (17th ed.) CitationH, Jung, Lee E, Ro JS, Lee JY, and Bang J. "Mortality After Acute Coronary Syndrome in Human Immunodeficiency Virus Infection with Optimal Adherence: A Nationwide Study." Infection & Chemotherapy 55, no. 4 (2023): 471. https://doi.org/10.3947/ic.2023.0050.
MLA (9th ed.) CitationH, Jung, et al. "Mortality After Acute Coronary Syndrome in Human Immunodeficiency Virus Infection with Optimal Adherence: A Nationwide Study." Infection & Chemotherapy, vol. 55, no. 4, 2023, p. 471, https://doi.org/10.3947/ic.2023.0050.